Goodson William H, Moore Dan H
Department of Surgery, California Pacific Medical Research Institute, 2100 Webster, Suite 401, San Francisco, CA 94115, USA.
Arch Intern Med. 2002 Jun 24;162(12):1343-8. doi: 10.1001/archinte.162.12.1343.
Understanding sources of physician delay in diagnosis of breast cancer will assist efforts to expedite diagnosis.
To test whether increased reliance on screening mammography has affected causes of physician delay in diagnosis of breast cancer.
Survey of delays in a case series.
Practice specializing in breast diseases in a region with high use of screening mammography.
Four hundred thirty-five consecutive patients treated for 454 breast cancers of any stage.
Customary patient care.
Whether delay was related to how cancer was identified, patient age, individual cancer characteristics (such as tumor type), mammography reports, or physician expertise.
Twenty-one women (5%) were inappropriately reassured that a malignant lump was benign without biopsy, 14 women (3%) had a misread mammogram, 4 women (1%) had a misread pathologic finding, and 5 women (1%) had cancer missed by a poorly performed fine-needle aspiration biopsy. Delay was associated with a benign mammography report (relative risk, 10.8; 95% confidence interval, 5.1-22.8), a woman finding her own mass (relative risk, 3.3; 95% confidence interval, 1.8-6.2), and current hormone replacement therapy (relative risk, 3.1; 95% confidence interval, 1.2-8.5).
The leading cause of physician delay in diagnosis of breast cancer continues to be inappropriate reassurance that a mass is benign without biopsy. Reducing delay in diagnosis will require less willingness to rely on clinical examination to decide that a mass is benign, less reliance on benign mammography reports to decide not to biopsy a mass, and a requirement that fine-needle aspiration biopsy be done by persons with demonstrated competence for the procedure.
了解医生在乳腺癌诊断中延迟的原因将有助于加快诊断。
测试对乳腺钼靶筛查的更多依赖是否影响了医生在乳腺癌诊断中延迟的原因。
对一系列病例中的延迟情况进行调查。
在一个乳腺钼靶筛查使用率高的地区,一家专门诊治乳腺疾病的医疗机构。
连续435例接受任何阶段454例乳腺癌治疗的患者。
常规患者护理。
延迟是否与癌症的发现方式、患者年龄、个体癌症特征(如肿瘤类型)、乳腺钼靶报告或医生专业知识有关。
21名女性(5%)在未进行活检的情况下被不恰当地告知恶性肿块为良性;14名女性(3%)乳腺钼靶检查结果被误读;4名女性(1%)病理检查结果被误读;5名女性(1%)因细针穿刺活检操作不当而漏诊癌症。延迟与乳腺钼靶检查报告为良性(相对危险度,10.8;95%可信区间,5.1 - 22.8)、女性自行发现肿块(相对危险度,3.3;95%可信区间,1.8 - 6.2)以及当前激素替代疗法(相对危险度,3.1;95%可信区间,1.2 - 8.5)有关。
医生在乳腺癌诊断中延迟的主要原因仍然是在未进行活检的情况下不恰当地告知肿块为良性。减少诊断延迟需要减少依赖临床检查来判定肿块为良性的意愿,减少依赖乳腺钼靶检查报告为良性而决定不对肿块进行活检的情况,并要求由具备该操作能力的人员进行细针穿刺活检。